Perzinfotel

DB12365InvestigationalSmall molecule

Perzinfotel has been used in trials studying the treatment of Diabetes Mellitus and Diabetic Neuropathy, Painful.

Mechanism: Pharmacologically active on Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B, and Glutamate receptor ionotropic, NMDA 2C
Curator reviewed
Formula / weight: C₉H₁₃N₂O₅P · 260.186 g/mol (avg)
Code names: EAA-090

Resolves to

Compound

Structure

InChIKeyBDABGOLMYNHHTR-UHFFFAOYSA-NSMILESOP(O)(=O)CCN1CCCNC2=C1C(=O)C2=O

Targets

What you can answer from here — as of July 07, 2026

5Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

9+ReferencesStructured and connected to the statements they support

Which drugs share a target with Perzinfotel, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.